PF-04802540

DRUG3 trials

Sponsors

Taisho Pharmaceutical Co., Ltd.

Conditions

HealthySchizophrenia

Phase 1

Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers

CompletedNCT00756743

Taisho Pharmaceutical Co., Ltd.Healthy

Start: 2008-09-30End: 2009-01-31Updated: 2010-03-19

A Study Of The Effect Of PF-04802540 On Sleep Measures

CompletedNCT00772512

Taisho Pharmaceutical Co., Ltd.Healthy

Start: 2008-11-30End: 2009-02-28Updated: 2010-03-19

Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia

CompletedNCT00876304

Taisho Pharmaceutical Co., Ltd.Schizophrenia

Start: 2009-04-30End: 2009-09-30Updated: 2010-03-19